Angiotensin II in central nervous system physiology

Regulatory Peptides

Volumn 78, Issue 1-3, 1998, Pages 1-11

  Phillips, M Ian ^a   Sumners, Colin ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensin receptors; AT1; AT2; Signaling pathways

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR;

ADRENERGIC SYSTEM; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; HUMAN; HYPOTHALAMUS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL PROCESSING;

ANGIOTENSIN II; BRAIN; CARDIOVASCULAR PHYSIOLOGY; CENTRAL NERVOUS SYSTEM; HYPERTENSION; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 0032583132     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00122-0     Document Type: Review

References (116)

1. [1] Tiegerstedt R, Bergman PG. Niere und Kreislauf. Skand Arch Physiol 1898;8:223-31.
2. [2] Munoz MJ, Braun-Mendendez E, Fasciolo JD, Leloir LF. Hypertensin: The substance causing renal hypertension. Nature 1939;144:980.
3. [3] Page IH, Helmer OM. A crystaline pressor substance (angiotonin) resulting from the action between renin and renin-activator. J Exp Med 1940;71:29-42.
4. [4] Skeggs LT, Kahn JR, Lentz KE, Shumway NP. The preparation, purification and amino acid sequence of a polypeptide renin substrate. J Exp Med 1957;106:439-53.
5. [5] Elliott DF, Peart WS. Amino acid sequence in a hypertensin. Nature 1956;177:527-8.
6. [6] Gross F. Adrenocortical function and renal pressor mechanisms in hypertension. In: Bock KD, Cottier PT, editors. Essential hypertension. Berlin: Springer-Verlag, 1960:92-111.
7. [7] Bickerton RK, Buckley JP. Evidence for a central mechanism in angiotensin induced hypertension. Proc Soc Expt Biol Med 1961;106:834-9.
8. [8] Sirrett NE, McLean AS, Bray JJ, Hubbard JI. Distribution of angiotensin II receptors in rat brain. Brain Res 1977;122:299-312.
9. [9] Fitzsimons JT. Thirst Physiol Rev 1972;52:468-561.
10. [10] Ganten D, Fuxe J, Phillips MI, Mann JFE. The brain isorenin angiotensin system: biochemistry, localization and possible role in drinking and blood pressure regulations. In: Ganong WF, Martini L, (Eds.) Frontiers in endocrinology. New York: Raven Press, 1978:61.
11. [11] Phillips MI, Weyhenmeyer JA, Felix D, Ganten D. Evidence for an endogenous brain renin angiotensin system. Fed Proc 1979;38:2260-6.
12. [12] Ganten D, Hermann K, Bayer C, Unger T, Lang RE. Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science Washington DC 1983;221:869-71.
13. [13] Phillips MI, Stenstrom B. Angiotensin II in rat brain comigrates with authentic angiotensin II in HPLC. Circ Res 1985;56:212-9.
14. [14] Hermann K, Lang RE, Unger T, Bayer C, Ganten D. Combined high-performance liquid chromatography radioimmunoassay for the characterization and quantitative measurement of neuropeptides. J Chromatogr 1984;312:273.
15. [15] Lynch KR, Simnad VI, Ben-Ari ET, Garrison JC. Localization of angiotensinogen messenger RNA sequences in the rat brain. Hypertension 1986;8:540-3.
16. [16] Dzau VJ, Ingelfinger J, Pratt RE, Ellison KE. Identification of renin and angiotensinogen messenger RNA sequences in rat brain. Hypertension 1986;8:544-8.
17. [17] Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin-angiotensin systems. Regul Pept 1992;43:1-20.
18. [18] Dzau VJ. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol 1984;6(Suppl 2):S377-82.
19. [19] Lightman A, Jones CL, MacLusky NJ, Palumbo A, DeCherney AH, Naftolin F. Immunocytochemical localization of angiotensin II immunoreactivity and demonstration of angiotensin II binding in the rat ovary. Am J Obstet Gynecol 1988; 159:526-30.
20. [20] Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWW. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;165:196-203.
21. [21] Whitebread S, Mele M, Kamber B, deGasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Comm 1989;163:284-8.
22. [22] Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin receptor. Nature 1991;351:233-6.
23. [23] Iwai N, Yamano Y, Chak S, Konishi F, Bardham S, Tibbetts C, Sasaki K, Hasegawa M, Matsuda Y, Inagami T. Rat angiotensin II receptor: cDNA sequence and regulation of gene expression. Biochem Biophys Res Comm 1991;177:299-304.
24. [24] Kambayashi Y, Bardham S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993;268:24543-6.
25. [25] Mukoyama M, Nakajiima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type-2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993;268:24539-42.
26. 4 and their functions. Regul Pept 1995;59:269.
27. [27] Moriguchi A, Morris M, Brosnihan KB, Ferrario CM. Angiotensin II and angiotensin (1-7) augment the local release of vasopressin from the paraventricular nucleus (PVN) and the supraoptic nucleus (SON), Abstract #240. Hypertension 1993;21:587.
28. [28] Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD. Angiotensin II type 1 receptor cDNAs: differential tissue expression and hormonal regulation. Biochem Biophys Res Comm 1992;183:1090-6.
29. [29] Phillips MI. Functions of brain angiotensin. Ann Rev Physiol 1987;49:413-35.
30. [30] Brody MJ, Faber JE, Mangiapane ML, Porter JP. The central nervous system and prevention of hypertension. In: deJong W, editor. Handbook of hypertension, experimental and genetic models of hypertension. New York: Elsevier, 1984;4:474-97.
31. [31] Bealer SL, Phillips MI, Johnson AK, Schmid PG. Anteroventral third ventricle lesions reduce antidiuretic responses to angiotensin II. Am J Physiol 1979;236:E610-5.
32. [32] Tsukashima A, Tsuchihashi T, Abe I, Nakamura K, Uchimura H, Fujishima M. Angiotensin II increases norepinephrine turnover in the anteroventral third ventricle of spontaneously hypertensive rats. Hypertension 1996;28:224-7.
33. [33] Gardiner SM, Bennett T. Endogenous vasopressin and baroreflex mechanisms. Brain Res Rev 1974;11:317-34.
34. [34] Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 1982;4:275-326.
35. [35] Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994;74(2):323-64.
36. [36] Loewy AD. Central autonomic pathways. In: Loewy AD, Spyer KM, editors. Central regulation of autonomic functions. New York: Oxford University Press, 1990:88-103.
37. [37] Reis DJ, Morrison S, Ruggiero DA. The C1 area of the brainstem in tonic and reflex control of blood pressure. Hypertension 1988;11(Suppl.):I8-I13.
38. [38] Ruggiero DA, Cravo SL, Arango V, Reis DJ. Central control of the circulation by the rostral ventrolateral reticular nucleus-anatomical substrates. In: Ciriello J, Caverson MM, Polosa C, editors. Central neural organization of cardiovascular control - progress in brain research. Amsterdam: Elsevier, 1989;81:49-79.
39. [39] Foote SL, Bloom FE, Aston-Jones G. Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol Rev 1983;63:844-914.
40. [40] Song K, Allen AM, Paxinos G, Mendelsohn FAO. Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J Comp Neurol 1992;316:467-84.
41. 1 receptor-like immunoreactivity in catecholaminergic neurons of the rat medulla oblongata. Neuroscience 1997;81(2):503-15.
42. [42] Miyawaki T, Kawamura H, Komatsu K, Yasugi T. Chemical stimulation of the locus coeruleus: inhibitory effects on hemodynamics and renal sympathetic nerve activity. Brain Res 1991;568:101-8.
43. [43] Carrive P, Bandler R. Viscerotropic organization of neurons subserving hypotensive reactions within the midbrain periaqueductal grey. A correlative functional and anatomical study. Brain Res 1991;541:206-15.
44. [44] Willette RN, Punnen S, Krieger AJ, Sapru HN. Interdependence of rostral and caudal ventrolateral medullary areas in the control of blood pressure. Brain Res 1984;321:169-74.
45. [45] Ross CA, Ruggiero DA, Reis DJ. Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla. J Comp Neurol 1985;242:511-34.
46. [46] Paton JFR, Spyer KM. Brainstem regions mediating the cardiovascular responses elicited from the posterior cerebellar cortex in the rabbit. J Physiol London 1990;427:533-52.
47. [47] Doba N, Reis DJ. Changes in regional blood flow and cardiodynamics evoked by electrical stimulation of the fastigial nucleus in the cat and their similarity to orthostatic reflexes. J Physiol London 1972;227:729-47.
48. [48] Bradley DJ, Paton JFR, Spyer KM. Cardiovascular responses evoked from the fastigial region of the cerebellum in anesthetized and decerebrate rabbits. J Physiol London 1987;392:475-92.
49. [49] Trolliet MR, Phillips MI. The effect of chronic bilateral nephrectomy on plasma and brain angiotensin. J Hypertens 1992;10:29-36.
50. [50] Saavedra JM, Correa FMA, Plunkett LM, Israel A, Kurihara M, Shigematsu K. Binding of angiotensin and atrial natriuretic peptide in brain of hypertensive rats. Nature 1986;320:758-60.
51. [51] Tsutsumi K, Viswanathan M, Stromberg C, Saavedra JM. Type-1 and type-2 angiotensin II receptors in fetal rat brain. Eur J Pharmacol 1991;198:89-92.
52. [52] Mendelsohn FAO. Localization and properties of angiotensin receptors. J Hyperten 1985;3:307-16.
53. 1 receptors in the brain. Regul Pept 1993;44(2):95-107.
54. 2) receptors in rat brin. Brain Res 1994;662:45-59.
55. [55] Phillips MI, Camacho A. Neural connections of the organum vasculosum of the lamina terminalis. In: Gross P, editor. Circumventricular Organs and Body Fluids, Vol. I. 1987:157-69.
56. [56] Miselis RR. The efferent projections of the subfornical organ of the rat. Brain Res 1981;230:1-8.
57. [57] McKinley MJ, McAllen RM, Mendelsohn FAO, Allen AM, Chai SY, Oldfield BJ. Circumventricular organs: Neuroendocrine interfaces between the brain and the hemal milieu. Frontiers Neuroendocrinol 1990;11:91-127.
58. [58] Phillips MI. Brain angiotensin. In: Gross P, editor. Circumventricular Organs and Body Fluids, Vol. III. Boca Raton: CRC Press, 1987:163-82.
59. [59] Chiu AT, McCall DE, Price WA, Wong PC, Carini DJ, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PBMWM. Non-peptide angiotensin II receptor antagonists VII. Cellular and biochemical pharmacology of DuP753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;252:711-22.
60. [60] Garcia-Sainz JA, Macias-Silvas M. Angiotensin II stimulates phosphoinositide turnover and phosphorylase through AII-1 receptors in isolated rat heptocytes. Biochem Biophys Res Comm 1990;172:780-4.
61. [61] Balla T, Baukal AJ, Eng S, Catt KJ. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharmacol 1991;40:401-6.
62. [62] Ko Y, Görg A, Appenheimer M, Wieczorek AJ, Düsing R, Vetter H, Sachinidis A. Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signaling system in vascular smooth muscle cells. Eur J Pharmacol 1992;227:215-9.
63. [63] Bauer PH, Chiu AT, Garrison JC. DuP753 can antagonize the effects of angiotensin II in the rat liver. Mol Pharmacol 1991;39:579-86.
64. [64] Marrero MB, Paxton WB, Schieffer B, Ling BN, Bernstein KE. Angiotensin II signaling events mediates by tyrosine phosphorylation. Cell Signaling 1996;8:21-6.
65. 2+ currents: intracellular mechanisms. Am J Physiol 1996;271:C154-63.
66. + current in cultured neurons: role of calcium/calmodulin-dependent protein kinase II. FASEB J 1998;12:A454.
67. [67] Huang X-C, Richards EM, Sumners C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem 1996;271:15635-41.
68. [68] Yang H, Lu D, Yu K, Raizada MK. Regulation of the neuromodulatory actions of angiotensin II in brain neurons by the RAS-dependent mitogen-activated protein kinase pathway. J Neurosci 1996;16:4047-58.
69. [69] Huang X-C, Deng T, Sumners C. Angiotensin II stimulates activation of Fos-Regulating kinase and c-Jun NH-terminal kinase in neuronal cultures from rat brain. Endocrinology 1998;139:245-51.
70. [70] Yang CR, Phillips MI, Renaud LP. Angiotensin II receptor activation depolarizes rat supraoptic neurons in vitro. Am J Physiol Reg Integ Comp Physiol 1992;321:R1333-8.
71. [71] Lokuta AJ, Cooper C, Gaa ST, Wang HE, Rogers TB. Angiotensin II stimulates the release of phospholipid derived second messengers through multiple receptor subtypes in heart cells. J Biol Chem 1994;269:4832-8.
72. 2 signaling in rabbit proximal tubule epithelial cells. Hypertension 1996;28:663-8.
73. 2 and arachidonic acid. J Neurosci 1998;18:679-86.
74. 1 receptor: gain of function study. Proc Natl Acad Sci USA 1995;92:10663-7.
75. [75] Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, Nahmias C. Angiotensin II type 2 receptors mediate inhibition of mitogen activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J 1997;325:449-56.
76. [76] Huang X-C, Richards EM, Sumners C. Angiotensin II type 2 receptor-mediated stimulation of protein phosphatase 2A in rat hypothalamic/brainstem neuronal co-cultures. J Neurochem 1995;65:2131-7.
77. [77] Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996;93(1):156-60.
78. [78] Gyurko R, Kimura B, Kurian P, Crews FT, Phillips MI. Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices. Biochem and Biophys Res Comm Vol 1992;186(1):285-92.
79. 2 receptor antagonist. Eur J Pharmacol 1995;275:277-82.
80. [80] Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioral and cardiovascular effects of disrupting the angiotensin II type 2 receptor in mice. Nature 1995;377:744-7.
81. [81] Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Miimura F, Ichikawa I, Hogan BL, Inagami T. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type 2 receptor. Nature 1995;377:748-50.
82. [82] Jones C, Millan MA, Naftolin F, Aguilera G. Characterization of angiotensin II receptors in the rat fetus. Peptides 1991;10:459-63.
83. [83] Millan MA, Kiss A, Aguilera G. Developmental changes in brain angiotensin II receptors in the rat. Peptides 1991;12:723-37.
84. [84] Phillips MI, Kimura B, Gyurko R. Angiotensin receptor stimulation of transforming growth factor-β (TGF-β) in rat skin and wound healing. In: Saavedra JM, Timmermans PBMWM, editors. Angiotensin Receptors. New York: Plenum Press, 1994:377-96.
85. [85] Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apopotosis. J Biol Chem 1997;272(30):19022-6.
86. [86] Pfister J, Felix D, Imboden H. Immunohistochemical demonstration of angiotensin II receptors in rat brain by use of an anti-idiotypic antibody. Regul Pept 1993;44:109-17.
87. [87] Johnson AK, Buggy J. Periventricular preoptic-hypothalamus is vital for thirst and normal water economy. Am J Physiol 1978;234:R122-9.
88. [88] Hogarty DC, Tran DN, Phillips MI. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin. Brain Res 1994;637:126-32.
89. [89] McKinley MJ, McAllen RM, Mendelsohn FAO, Allen AM, Chai SY, Oldfield BJ. Circumventricular organs: Neuroendocrine interfaces between the brain and the hemal milieu. Frontiers Neuroendocrinol 1990;11:91-127.
90. [90] Thornton SN, Nicolaidis S. Long-term mineralocorticoid-induced changes in rat neuron properties plus interaction of aldosterone and Ang II. Am J Physiol 1994;266:R564-71.
91. [91] Casto R, Phillips MI. Neuropeptide action in nucleus tractus solitarius: Angiotensin specificity in hypertensive rats. Am J Physiol 1985;249:R341-7.
92. [92] Smythies O. A mouse view of hypertension. Hypertension 1997;30:1318-24.
93. [93] Phillips MI. The contribution of central angiotensin II to the hypertension of spontaneously hypertensive rats. In: Schmitt H, Meyer P, editors. Nervous System and Hypertension. New York: John Wiley and Son, 1978:102-05.
94. [94] Ganten D, Hutchinson S, Schelling P. The intrinsic brain iso-renin angiotensin system: Its possible role in central mechanisms of blood pressure. Clin Sci Mol Med 1975;48:265S-8S.
95. [95] Phillips MI, Mann JFE, Haebara H, Hoffman WE, Dietz R, Schelling P, Ganten D. Lowering of hypertension by central saralasin in the absence of plasma renin. Nature 1977;270:445-7.
96. [96] Sweet CS, Columbo JM, Gaul SC. Central antihypertensive effects of inhibitors of the renin-angiotensin system in rats. Am J Phys 1976;231:1794-9.
97. [97] Schoelkens BA, Jung W, Steinbach R. Blood pressure response to control and peripheral injection of angiotensin II and 8-C-phenylglycine analogue of angiotensin II in rats with experimental hypertension. Clin Sci Mol Med 1976;51:403S-6S.
98. [98] Kamitani A, Higashimori K, Kohara K, Higaki J, Mikami H, Ogihara T. The effects of central administration of angiotensin II type-1 receptor antagonist, CV-22974, in nephrectomized spontaneously hypertensive rats. Clin Exper Pharmacol Physiol 1994;21:271-6.
99. 1 receptor lowers blood pressure in salt-sensitive rats. Hypertension 1992;20:755-62.
100. [100] Bruner CA, Fink GD. Cerebroventricular infusion of angiotensin antagonist does not influence hypertensive response to blood-borne angiotensin II. Brain Res 1985;360:15-23.
101. [101] Berecek KH, Okuno T, Nagahama S, Oparil S. Altered vascular reactivity and baroreflex sensitivity induced by chronic administration of captopril in the spontaneously hypertensive rat. Hypertension 1993;5:689-700.
102. [102] Sweet CS, Arbegast PT, Gaul SL, Blaine EH, Gross DM. Relationship between angiotensin blockade and hypertensive properties of single doses of MK421 and captopril in spontaneous and renal hypertensive rats. Eur J Pharmacol 1981;76:167-76.
103. [103] Phillips MI, Kimura BK. Levels of brain angiotensin in the spontaneously hypertensive rat and treatment with ramiprilat. J Hypertension 1986;4:S391-4.
104. [104] Yamashita Y, Takata Y, Takishita S, Kimura Y, Fukishima M. Enhancement of brain renin-angiotensin system induced by long term salt loading in SHR. J Hypertension 1986;4:S361-3.
105. [105] Phillips MI, Mann JF. Hypertension and sodium intake: Is the brain renin-angiotensin system salient? In: Iwai J, editor. Salt and Hypertension, Proceedings of the Lewis K. Dahl Symposium. New York/Tokyo: Igaku-Shoin, 1982:185-202.
106. [106] Kirby RF, Page WV, Johnson AK, Robillard JE. Dietary sodium effects of renin and angiotensinogen gene expression in preweanling WKY and SHR. Am J Physiol 1996;271:R1439-46.
107. [107] Avrith DB, Fitzsimons JT. Increased sodium appetite in the rat induced by intracranial administration of components of the renin-angiotensin system. J Physiol London 1980;301:349-64.
108. [108] Stamler JF, Brody MJ, Phillips MI. The central and peripheral effects of captopril (SQ 14225) on the arterial pressure of the spontaneously hypertensive rat. Brain Res 1980;186:499-503.
109. [109] Stamler JF, Raizada MK, Fellows RE, Phillips MI. Increased specific binding of angiotensin II in the organum vasculosum of the laminae terminalis area of the spontaneously hypertensive rat brain. Neurosci Lett 1980;17:173-7.
110. [110] Gehlert DR, Speth RC, Wamsley JK. Quantitative autoradiography of angiotensin II receptors in the spontaneously hypertensive rat brain. Peptides 1986;7:1021-7.
111. [111] Phillips MI, Camacho A. Neural connections of the organum vasculosum of the lamina terminalis. In: Gross P, editor. Circumventricular organs and body fluids, Vol. I, 1987:157-69.
112. [112] Miselis RR. The efferent projections of the subfornical organ of the rat. Brain Res 1981;230:1-8.
113. [113] Crofton JT, Share L, Shade RE, Allen C, Tarnowski D. Vasopressin in the rat with spontaneous hypertension. Am J Physiol 1987;235:H361-6.
114. [114] Sladek CD, Blair ML, Mangiapane M. Evidence against a pressor role for vasopressin in spontaneous hypertension. Hypertension 1987;9:332-8.
115. [115] Berecek KH, Wilson KM, Magargal W. Effect of lifetime captopril treatment on drinking, peripheral vascular reactivity and angiotensin II receptor binding. Hypertension 1987;9:527 Abstract.
116. [116] Berecek KH, Okuno T, Nagahama S, Oparil S. Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat. Hypertension 1983;5:689-700.